Allogene Therapeutics, Inc. · NASDAQ:ALLO
Parker Geoffrey M. sold 36,342 Allogene Therapeutics, Inc. shares (Form 4)
Traded Oct 21, 2026 · Filed Oct 23, 2026
On Oct 21, 2026, Parker Geoffrey M. (CHIEF FINANCIAL OFFICER) sold 36,342 Allogene Therapeutics, Inc. shares at US$1.34 for US$48,698, leaving 1,045,877 shares. Filed Oct 23, 2026 (Form 4).
- Sold
- 36,342 shares
- Price
- US$1.34
- Value
- US$48,698
- Holding after
- 1,045,877 shares
- Trading plan
- No
- Role
- CHIEF FINANCIAL OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 21, 2026 | Common Stock | Sale | 36,342 | US$1.34 | 1,045,877 | Direct |
Source
Download original · View original at SEC
Related
- Allogene Therapeutics, Inc.
- Parker Geoffrey M.
- Allogene Therapeutics, Inc. shareholders
- Schedule 13D/A · Tpg Gp A, LLC · Sep 30, 2026
- Form 4 · Douglas Earl Martin · Aug 25, 2026
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · Aug 14, 2026
- Schedule 13G/A · Arie Belldegrun, M.D. · Aug 7, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026